Matches in SemOpenAlex for { <https://semopenalex.org/work/W2747964726> ?p ?o ?g. }
- W2747964726 endingPage "5408" @default.
- W2747964726 startingPage "5395" @default.
- W2747964726 abstract "Abstract Triple-negative breast cancers (TNBC) are highly aggressive, lack FDA-approved targeted therapies, and frequently recur, making the discovery of novel therapeutic targets for this disease imperative. Our previous analysis of the molecular mechanisms of action of bromodomain and extraterminal protein inhibitors (BETi) in TNBC revealed these drugs cause multinucleation, indicating BET proteins are essential for efficient mitosis and cytokinesis. Here, using live cell imaging, we show that BET inhibition prolonged mitotic progression and induced mitotic cell death, both of which are indicative of mitotic catastrophe. Mechanistically, the mitosis regulator LIN9 was a direct target of BET proteins that mediated the effects of BET proteins on mitosis in TNBC. Although BETi have been proposed to function by dismantling super-enhancers (SE), the LIN9 gene lacks an SE but was amplified or overexpressed in the majority of TNBCs. In addition, its mRNA expression predicted poor outcome across breast cancer subtypes. Together, these results provide a mechanism for cancer selectivity of BETi that extends beyond modulation of SE-associated genes and suggest that cancers dependent upon LIN9 overexpression may be particularly vulnerable to BETi. Cancer Res; 77(19); 5395–408. ©2017 AACR." @default.
- W2747964726 created "2017-08-31" @default.
- W2747964726 creator A5005628876 @default.
- W2747964726 creator A5008925587 @default.
- W2747964726 creator A5009805608 @default.
- W2747964726 creator A5020136425 @default.
- W2747964726 creator A5025139820 @default.
- W2747964726 creator A5031688955 @default.
- W2747964726 creator A5031917882 @default.
- W2747964726 creator A5035038770 @default.
- W2747964726 creator A5046497930 @default.
- W2747964726 creator A5053038262 @default.
- W2747964726 creator A5053269103 @default.
- W2747964726 creator A5065849539 @default.
- W2747964726 creator A5082477755 @default.
- W2747964726 date "2017-10-01" @default.
- W2747964726 modified "2023-10-10" @default.
- W2747964726 title "Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors" @default.
- W2747964726 cites W1480226100 @default.
- W2747964726 cites W1908864745 @default.
- W2747964726 cites W1966227037 @default.
- W2747964726 cites W1966680971 @default.
- W2747964726 cites W1971578941 @default.
- W2747964726 cites W1976033223 @default.
- W2747964726 cites W1989529289 @default.
- W2747964726 cites W1997367417 @default.
- W2747964726 cites W2002395443 @default.
- W2747964726 cites W2005895632 @default.
- W2747964726 cites W2010457001 @default.
- W2747964726 cites W2012575446 @default.
- W2747964726 cites W2016599680 @default.
- W2747964726 cites W2024341581 @default.
- W2747964726 cites W2026143081 @default.
- W2747964726 cites W2030864103 @default.
- W2747964726 cites W2032551913 @default.
- W2747964726 cites W2041535798 @default.
- W2747964726 cites W2043398720 @default.
- W2747964726 cites W2044224053 @default.
- W2747964726 cites W2045067678 @default.
- W2747964726 cites W2045897698 @default.
- W2747964726 cites W2057460011 @default.
- W2747964726 cites W2060484997 @default.
- W2747964726 cites W2085934079 @default.
- W2747964726 cites W2105132188 @default.
- W2747964726 cites W2114843025 @default.
- W2747964726 cites W2128187370 @default.
- W2747964726 cites W2128985829 @default.
- W2747964726 cites W2130410032 @default.
- W2747964726 cites W2134051389 @default.
- W2747964726 cites W2135630561 @default.
- W2747964726 cites W2139731421 @default.
- W2747964726 cites W2142739240 @default.
- W2747964726 cites W2146512944 @default.
- W2747964726 cites W2147714160 @default.
- W2747964726 cites W2148708580 @default.
- W2747964726 cites W2149441684 @default.
- W2747964726 cites W2150693815 @default.
- W2747964726 cites W2153454576 @default.
- W2747964726 cites W2156397151 @default.
- W2747964726 cites W2164721923 @default.
- W2747964726 cites W2167823163 @default.
- W2747964726 cites W2170551349 @default.
- W2747964726 cites W2170637386 @default.
- W2747964726 cites W2171808845 @default.
- W2747964726 cites W2176431841 @default.
- W2747964726 cites W2176757944 @default.
- W2747964726 cites W2226721679 @default.
- W2747964726 cites W2339081537 @default.
- W2747964726 cites W2375577403 @default.
- W2747964726 cites W2432855159 @default.
- W2747964726 cites W2523041838 @default.
- W2747964726 cites W2568702006 @default.
- W2747964726 cites W2604873860 @default.
- W2747964726 doi "https://doi.org/10.1158/0008-5472.can-17-1571" @default.
- W2747964726 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5626629" @default.
- W2747964726 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28807940" @default.
- W2747964726 hasPublicationYear "2017" @default.
- W2747964726 type Work @default.
- W2747964726 sameAs 2747964726 @default.
- W2747964726 citedByCount "24" @default.
- W2747964726 countsByYear W27479647262017 @default.
- W2747964726 countsByYear W27479647262018 @default.
- W2747964726 countsByYear W27479647262019 @default.
- W2747964726 countsByYear W27479647262020 @default.
- W2747964726 countsByYear W27479647262021 @default.
- W2747964726 countsByYear W27479647262022 @default.
- W2747964726 countsByYear W27479647262023 @default.
- W2747964726 crossrefType "journal-article" @default.
- W2747964726 hasAuthorship W2747964726A5005628876 @default.
- W2747964726 hasAuthorship W2747964726A5008925587 @default.
- W2747964726 hasAuthorship W2747964726A5009805608 @default.
- W2747964726 hasAuthorship W2747964726A5020136425 @default.
- W2747964726 hasAuthorship W2747964726A5025139820 @default.
- W2747964726 hasAuthorship W2747964726A5031688955 @default.
- W2747964726 hasAuthorship W2747964726A5031917882 @default.
- W2747964726 hasAuthorship W2747964726A5035038770 @default.
- W2747964726 hasAuthorship W2747964726A5046497930 @default.
- W2747964726 hasAuthorship W2747964726A5053038262 @default.